GLP-1 medications like semaglutide and tirzepatide help people lose weight by reducing appetite, but they come with a hidden cost: muscle loss. As people eat less while taking these drugs, they often lose lean mass alongside fat, which weakens bones, slows metabolism, and increases injury risk.
Women's Health addresses this challenge with a strength-focused guide designed specifically for GLP-1 users. The plan recognizes that standard weight-loss advice falls short for people on these medications. When calorie intake drops dramatically, the body breaks down muscle for energy unless resistance training actively preserves it.
The core strategy centers on three elements. First, consistent strength training targets all major muscle groups through compound movements like squats, deadlifts, and push variations. These exercises signal the body to retain muscle even during weight loss. Second, adequate protein intake becomes non-negotiable. Research shows that people on GLP-1s need higher protein percentages of their total calories to prevent muscle breakdown, since their overall calorie consumption drops so sharply. Third, strategic eating timing around workouts helps maximize muscle protein synthesis when the body is primed to build or maintain tissue.
The plan addresses practical barriers unique to GLP-1 users. Many experience nausea or reduced appetite, making it harder to eat protein-rich meals. The guide offers smaller, nutrient-dense options and timing suggestions to work around medication side effects. It also outlines how to modify training intensity for days when energy levels dip from lower food intake.
GLP-1 medications work best when combined with lifestyle changes, not as replacements for them. People who use these drugs without strength training often regain weight quickly once they stop, and they've lost muscle mass in the process. Building and maintaining strength during GLP-1 therapy creates a foundation for long-term weight management and better overall health outcomes.
This